BIOMEDevice San Jose is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.

PANEL: The New Era of Minimally Invasive Surgery

Dr. Carter Lebares (Assistant Professor of Surgery, Division of General Surgery, Director, UCSF)

Dr. Insoo Suh (Assistant Professor of Surgery, Division of General Surgery, Endocrine Surgery Section, UCSF)

Dr. Alberto Rodriguez-Navarro (CEO, Levita Magnetics)

Daphne Allen (Chief Editor, MD+DI)

Location: Booth 641

Date: Thursday, December 5

Time: 12:45pm - 1:30pm

Track: Center Stage

Format: Panel

Session Type: Panel

Vault Recording: TBD

Audience Level: All

Join our panel for an in-depth look at the design thinking and new technology being deployed in the product development processes by leading manufacturers of minimally invasive products for cardiovascular, neurovascular, endovascular, and other interventional procedures. Panelists will discuss what they feel are the next areas of unmet need for products in the minimally invasive surgical space. Attendees will get an intimate look at how top innovators think and work, as well as take home tips to inspire their own product development teams to achieve greatness. Topics covered include:

  • The latest in surgical technology, tools, and systems
  • Design challenges for minimally invasive devices, including a look at current materials being used
  • A look at miniaturization of devices
  • Innovating within market constraints to provide new solutions to old problems
  • Buying criterion: value analysis on what is worth investing in